Should the association between SIRT6 and AIS-related mortality be confirmed, circulating levels of SIRT6 could help stratifying the risk of patients with AIS, in order to optimize the management of the patients with highest risk. Here, SIRT6 is linked to androgen insensitivity syndrome.